Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a601013 |
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H17FN4O3 |
Molar mass | 320.324 g·mol−1 |
3D model (JSmol) | |
Melting point | 220 to 224 °C (428 to 435 °F) |
| |
| |
(verify) |
Enoxacin[note 1] is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Insomnia is a common adverse effect.[1][2] It is no longer available in the United States.
Enoxacin may have cancer inhibiting effect.[3]
Cite error: There are <ref group=note>
tags on this page, but the references will not show without a {{reflist|group=note}}
template (see the help page).